Tezspire Phase III Nasal Polyp Data May Lead To Second Indication

 
• By Joseph Haas
  
AstraZeneca and Amgen hope to file Tezspire for nasal polyps with Phase III readout (Shutterstock)

More from Clinical Trials

More from Therapy Areas